Mass Balance Study of JTZ-951 in Subjects With End-stage Renal Disease on Hemodialysis
NCT02805244
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
Anemia of Chronic Kidney Disease
Interventions
DRUG:
JTZ-951, 14C-JTZ-951
Sponsor
Akros Pharma Inc.